CEA – CARCINO EMBRYONIC ANTIGEN

The CEA (Carcinoembryonic Antigen) test is a blood test used to measure the level of CEA, a protein that may be elevated in certain cancers, especially colorectal cancer. It is primarily used to monitor treatment effectiveness and detect recurrence in patients already diagnosed with cancer.

The purpose of this test is to:

• Measure CEA levels in the blood
• Monitor cancers such as colorectal cancer
• Evaluate treatment response
• Detect recurrence of cancer
• Support diagnosis along with other clinical tests

CEA – CARCINO EMBRYONIC ANTIGEN Test Purpose

The CEA (Carcinoembryonic Antigen) Test measures the level of carcinoembryonic antigen (CEA) in the blood. CEA is a tumor marker that is normally present in very low levels in healthy adults but may become elevated in certain types of cancer. The test is primarily used to monitor cancer treatment, assess disease progression, and detect cancer recurrence, rather than to diagnose cancer on its own.

Healthcare providers commonly recommend the CEA Test for individuals diagnosed with colorectal (colon and rectal) cancer, as it is one of the most widely used tumor markers for monitoring this condition. The test may also be helpful in patients with pancreatic, stomach (gastric), lung, breast, ovarian, medullary thyroid, and certain other cancers. It is often performed before treatment to establish a baseline CEA level and repeated during and after treatment to monitor response.

Furthermore, elevated CEA levels may indicate the presence of certain cancers or suggest that cancer has spread (metastasized). However, increased CEA levels can also occur in non-cancerous conditions, including smoking, liver disease, pancreatitis, inflammatory bowel disease (IBD), diverticulitis, chronic obstructive pulmonary disease (COPD), and other inflammatory conditions. Therefore, the CEA Test is not recommended as a screening test for cancer in healthy individuals and should always be interpreted together with clinical findings and imaging studies.

The CEA Test is often performed alongside other tumor markers such as CA 19-9, CA 125, CA 15-3, CA 72-4, Calcitonin, as well as CT Scan, MRI, PET-CT, Colonoscopy, and biopsy findings to provide a comprehensive evaluation of cancer status.

The test results should always be interpreted together with the patient’s symptoms, medical history, physical examination, imaging findings, and other laboratory investigations. Monitoring changes in CEA levels over time is generally more useful than relying on a single test result.

CEA – CARCINO EMBRYONIC ANTIGEN Test is Recommended for Individuals:

• Patients diagnosed with colorectal (colon or rectal) cancer.
• Individuals undergoing treatment for gastrointestinal or other CEA-producing cancers.
• Patients requiring monitoring for cancer recurrence after treatment.
• Individuals with suspected metastatic cancer as advised by their oncologist.
• Patients undergoing follow-up after surgery, chemotherapy, or radiation therapy.
• Individuals advised by their healthcare provider to undergo tumor marker monitoring.
• Patients requiring serial CEA measurements to assess treatment effectiveness.

FAQs

1. What is the CEA Test used for?

The CEA Test measures the level of carcinoembryonic antigen (CEA) in the blood. It is primarily used to monitor cancer treatment, assess disease progression, detect recurrence, and evaluate certain cancers, especially colorectal cancer.

2. Do I need to fast before the CEA Test?

Fasting is generally not required for the CEA Test. However, always follow any preparation instructions provided by your healthcare provider before sample collection.

3. Does a high CEA level always mean cancer?

No. An elevated CEA level does not always indicate cancer. Increased levels may also occur in smokers, as well as in conditions such as liver disease, pancreatitis, inflammatory bowel disease, diverticulitis, and chronic lung diseases. Your healthcare provider will interpret the results together with your symptoms, medical history, imaging studies, and other laboratory tests to determine the underlying cause.